Common Contracts
2 similar Shareholders Agreement contracts by AnPac Bio-Medical Science Co., Ltd.
August 17, 2017 Shareholders Agreement AnPac Bio-Medical Science Co., Ltd. A limited liability company incorporated in the British Virgin IslandsShareholders Agreement • October 31st, 2019 • AnPac Bio-Medical Science Co., Ltd. • Services-medical laboratories • Hong Kong
In this Agreement, Chris Chang Yu and CRS Company are hereinafter referred to individually as the “Founder” and collectively as the “Founders”; Founders and Ms Lin Yu are hereinafter referred to individually as the “Existing Major Shareholder” and collectively as the “Existing Major Shareholders”; EMPOWER Investment is hereinafter referred to individually as “Investor”; Existing Major Shareholders and other Shareholders of the Company shall be collectively referred to as the “Existing Shareholders”; Lishui Company, Yangzhou Company, Changwei Company, AnPac Shanghai Company, Xinshenpai Company, Medical Laboratory, Chengdu Company and AnPac U.S. are hereinafter referred to individually as the “Domestic And Foreign Company” and collectively as the “Domestic And Foreign Companies”; The Company and Domestic And Foreign Companies and all other direct or indirect, current or future subsidiaries of the above companies are referred to individually as “Group Company” and collectively as the “Gro
June 30, 2017 Shareholders Agreement AnPac Bio-Medical Science Co., Ltd. A limited liability company incorporated in the British Virgin IslandsShareholders Agreement • October 31st, 2019 • AnPac Bio-Medical Science Co., Ltd. • Services-medical laboratories • Hong Kong
In this Agreement, Chris Chang Yu and CRS Company are hereinafter referred to individually as the “Founder” and collectively as the “Founders”; Founders and Ms. Lin Yu are hereinafter referred to individually as the “Existing Major Shareholder” and collectively as the “Existing Major Shareholders”; Zhangjiang Science Investment and Zhijun Investment are referred to collectively as the “Investors” and individually as the “Investor”; Existing Major Shareholders and other Shareholders of the Company shall be collectively referred to as the “Existing Shareholders”; Lishui Company, Yangzhou Company, Changwei Company, AnPac Shanghai Company, Xinshenpai Company, Medical Laboratory, Chengdu Company and AnPac U.S. are hereinafter referred to individually as the “Domestic and Foreign company” and collectively as the “Domestic and Foreign Companies”; The Company and Domestic and Foreign Companies and all other direct or indirect, current or future Subsidiaries of the above companies are referred
